How Pfizer oncology is juggling 8 US launches
Did cancer clinical trials stay on track at ASCO 2019
Novartis licenses out antiviral work to Gilead
Five firms that could buy Celgene’s Otezla ahead of BMS merger
*scroll through previous pages at the bottom to get older news*
Want to stay updated on CP happenings? New features, new boards, CP wire articles, and more? Click here to subscribe
